Gt biopharma appoints manu ohri as chief financial officer

Brisbane, calif., feb. 18, 2022 /prnewswire/ -- gt biopharma, inc. (nasdaq: gtbp), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the company's proprietary natural killer (nk) cell engager, trike® protein biologic technology platform, today announced the appointment of manu ohri, who joins the company as its chief financial officer (cfo) effective immediately.
GTBP Ratings Summary
GTBP Quant Ranking